Meibomian Gland Dysfunction Clinical Trial
Official title:
Evaluation of Ocular Surface Changes Following RF Electrocoagulation Treatment of the Periorbital Region
This protocol will evaluate THERMIeyes® for its ability to treat periorbital skin laxity and wrinkles and monitor ocular surface changes and their effect on evaporative dry eye associated with MGD.
Subjects with skin laxity and evaporative dry eye will be recruited for enrollment in this study. Subjects must present with subjective and objective indicators for periorbital skin laxity and wrinkle grade of 2 or greater out of a 4 point scale. To qualify, subjects must present with high symptoms score on subjective Ocular Surface Disease Index© (OSDI©) Questionnaires (scores≥ 15); Rapid Tear Break up (< 5 seconds) and Grade ≥ 1 of Flourescein Staining in one area of the cornea. Each of these parameters are to be assessed prior to treatment and at each follow up visit. Treatment is to be performed on periorbital skin only around one eye of the subject using the THERMIeyes® standard protocol. This may result in some redness of the periorbital skin. Subjects are to be seen and treated 2-3 weeks apart for a total of 3 treatments. Subjects will be followed at 6 and 12 weeks after the final treatment. A Validated Grading Scale for Crow's Feet will be used to evaluate changes in skin wrinkles and dry eye signs and symptoms scores will be compared with pre-treatment findings. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
| Completed |
NCT04884243 -
Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
|
Phase 2 | |
| Active, not recruiting |
NCT04425551 -
Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction
|
N/A | |
| Terminated |
NCT02596919 -
Fast Infrared Meibography (Photography)
|
N/A | |
| Completed |
NCT01207752 -
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
|
N/A | |
| Completed |
NCT05162261 -
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
|
N/A | |
| Recruiting |
NCT06064071 -
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
|
N/A | |
| Completed |
NCT03652051 -
A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)
|
Phase 2 | |
| Recruiting |
NCT03767530 -
Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction
|
N/A | |
| Active, not recruiting |
NCT05577910 -
Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD
|
N/A | |
| Completed |
NCT04889950 -
Clinical Study to Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction
|
N/A | |
| Recruiting |
NCT06004895 -
Mechanisms of Light-based Therapies for Dry Eye Disease
|
N/A | |
| Completed |
NCT04147962 -
Intense Pulsed Light in Meibomian Gland Dysfunctions
|
||
| Completed |
NCT02256969 -
Intraductal Meibomian Gland Probing Trial
|
Phase 4 | |
| Recruiting |
NCT05089591 -
Intense Pulsed Light in Meibomian Gland Dysfunction
|
N/A | |
| Completed |
NCT04500821 -
Evaluation of the LipiFlow System With a New Activator
|
N/A | |
| Completed |
NCT03318874 -
Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction
|
Phase 4 | |
| Completed |
NCT06278584 -
iLux Treatment for Meibomian Gland Dysfunction
|
N/A | |
| Recruiting |
NCT04052841 -
Morphological Analysis of Meibomian Glands
|
N/A | |
| Completed |
NCT05028491 -
The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients
|